Drug Delivery Devices Market to Garner $26.74 Bn, Globally, by 2026 at 4.3% CAGR

Allied Market Research recently published a report, titled, "Drug Delivery Devices Market by Device Type (Smart Pills, Inhalers & Nebulizers, Drug Eluting Stents, Safety Syringes, Implantable Drug Delivery Device, and Transdermal Patches, and, Others), End User (Hospitals and Diagnostic Centers, Ambulatory Surgery Centers and Clinics and Others), Global Opportunity Analysis and Industry Forecast, 2019-2026". According to the report, the global drug delivery devices market was pegged at $19.06 billion in 2018, and is projected to hit $26.74 billion by 2026, growing at a CAGR of 4.3% from 2019 to 2026.

♦ 𝐒𝐢𝐦𝐩𝐥𝐲 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/request-sample/6460

Key Drivers of Market Growth

The global drug delivery devices market is expanding rapidly, driven by the rising prevalence of chronic diseases, a growing aging population, and the increasing demand for biologics. However, challenges such as the risk of needlestick injuries and stringent government regulations hinder market growth. Despite these barriers, emerging markets present significant opportunities for expansion in the near future.

Inhalers & Nebulizers Lead the Market

Among product segments, inhalers and nebulizers dominated the market in 2018, accounting for over one-third of the global share. This is primarily due to the increasing prevalence of asthma worldwide.
However, the smart pills segment is expected to experience the highest CAGR of 7.1% during the forecast period. This growth is driven by the advantages of smart pill technology, which enables real-time monitoring of drug administration, aiding drug development, candidate selection, and profiling.

Ambulatory Surgery Centers & Clinics to See Rapid Growth

The ambulatory surgery centers (ASCs) and clinics segment is projected to witness the highest CAGR of 5.3% through 2026. ASCs provide specialized medical services in fields such as orthopedics, ophthalmology, urology, and pain management, making them an essential part of the healthcare system.

However, in 2018, hospitals and diagnostic centers held the largest market share, accounting for over two-fifths of the global market. This dominance is attributed to greater resources, advanced medical facilities, and the ability to manage complex cases more effectively than ASCs.

♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/purchase-enquiry/A06095

North America Dominates, Asia-Pacific Shows Strong Growth

North America held the largest market share in 2018, contributing approximately 40% of the global market. This is due to the high prevalence of chronic conditions such as cancer and diabetes, which require specialized drug delivery devices.

However, the Asia-Pacific region is expected to register the fastest CAGR of 5.1% during the forecast period. Factors driving this growth include a rising diabetic population, increasing awareness of drug delivery technologies, and growing healthcare expenditures in countries like India and Japan.

Key Market Players

• AstraZeneca PLC
• 3M Company
• Becton, Dickinson and Company
• Consort Medical PLC
• Boehringer Ingelheim Group
• Insulet Corporation
• GlaxoSmithKline PLC
• Sulzer Ltd. (Medmix Systems AG)
• Medtronic PLC
• West Pharmaceutical Services, Inc.

𝐀𝐜𝐜𝐞𝐬𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/checkout-final/be9b2e632b8835f22639c77fce6cd7c9

𝗙𝗿𝗲𝗾𝘂𝗲𝗻𝘁𝗹𝘆 𝗔𝘀𝗸𝗲𝗱 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀?

Q1. What is the total market value of drug delivery devices market report?

Q2. What would be forecast period in the market report?

Q3. What is the market value of drug delivery devices market in 2019?

Q4. Which is base year calculated in the drug delivery devices market report?

Q5. Which are the top companies hold the market share in drug delivery devices market?

Q6. Which is the most influencing segment growing in the drug delivery devices market report?

♦ 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐰𝐢𝐭𝐡 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 -

Biobanking Market - https://www.alliedmarketresearch.com/biobanking-market

Cosmetic Dentistry Market - https://www.alliedmarketresearch.com/cosmetic-dentistry-market-A13684

Oligonucleotide Synthesis Market - https://www.alliedmarketresearch.com/oligonucleotide-synthesis-market-A08356

Surgical Robotics Market - https://www.alliedmarketresearch.com/Surgical-Robotics-market

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀 -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.